{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:25:07Z","timestamp":1790115907340,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Alnylam Pharmaceuticals, Italy"},{"DOI":"10.13039\/501100009882","name":"Regione Lombardia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Finalizzata (Progetto RF-2016-02361887)"],"award-info":[{"award-number":["Ricerca Finalizzata (Progetto RF-2016-02361887)"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kedrion Biopharma"},{"name":"CSL Behring"},{"DOI":"10.13039\/501100020412","name":"Humanitas Research Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013560","name":"GBS\/CIDP Foundation International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00415-025-13218-6","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:42:09Z","timestamp":1752680529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence of hereditary transthyretin amyloidosis in CIDP patients with red flags: a multicenter genetic screening and misdiagnosis analysis"],"prefix":"10.1007","volume":"272","author":[{"given":"Pietro Emiliano","family":"Doneddu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Falzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Luigetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Mataluni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinella","family":"Carpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Barilaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Filosto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Vegezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Inghilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Canale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Brighina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Mat\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Forcina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Siconolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mazzeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Mollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Risi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Moret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Todisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2624-8138","authenticated-orcid":false,"given":"Eduardo","family":"Nobile\u2013Orazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"13218_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","volume":"15","author":"D Adams","year":"2019","unstructured":"Adams D, Koike H, Slama M, Coelho T (2019) Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol 15:387\u2013404. https:\/\/doi.org\/10.1038\/s41582-019-0210-4","journal-title":"Nat Rev Neurol"},{"key":"13218_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/mus.26034","volume":"57","author":"HH Schmidt","year":"2018","unstructured":"Schmidt HH, Waddington-Cruz M, Botteman MF, Carter JA, Chopra AS, Hopps M, Stewart M, Fallet S, Amass L (2018) Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle Nerve 57:829\u2013837. https:\/\/doi.org\/10.1002\/mus.26034","journal-title":"Muscle Nerve"},{"issue":"20","key":"13218_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13023-025-03547-0","volume":"16","author":"D Delgado","year":"2025","unstructured":"Delgado D, Dabbous F, Shivappa N, Mazhar F, Wittbrodt E, Shridharmurthy D, J\u00e4rbrink K (2025) Epidemiology of transthyretin (ATTR) amyloidosis: a systematic literature review. Orphanet J Rare Dis 16(20):29. https:\/\/doi.org\/10.1186\/s13023-025-03547-0","journal-title":"Orphanet J Rare Dis"},{"key":"13218_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/13506129.2020.1794807","volume":"27","author":"M Russo","year":"2020","unstructured":"Russo M, Obici L, Bartolomei I, Cappelli F, Luigetti M, Fenu S, Cavallaro T, Chiappini MG, Gemelli C, Pradotto LG, Manganelli F, Leonardi L, My F, Sampaolo S, Briani C, Gentile L, Stancanelli C, Di Buduo E, Pacciolla P, Salvi F, Casagrande S, Bisogni G, Calabrese D, Vanoli F, Di Iorio G, Antonini G, Santoro L, Mauro A, Grandis M, Di Girolamo M, Fabrizi GM, Pareyson D, Sabatelli M, Perfetto F, Rapezzi C, Merlini G, Mazzeo A, Vita G (2020) ATTRv amyloidosis Italian Registry: clinical and epidemiological data. Amyloid 27:259\u2013265. https:\/\/doi.org\/10.1080\/13506129.2020.1794807","journal-title":"Amyloid"},{"key":"13218_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1172\/JCI111390","volume":"74","author":"MJ Saraiva","year":"1984","unstructured":"Saraiva MJ, Birken S, Costa PP, Goodman DS (1984) Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Investig 74:104\u2013119. https:\/\/doi.org\/10.1172\/JCI111390","journal-title":"J Clin Investig"},{"key":"13218_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3109\/07853890.2015.1068949","volume":"47","author":"PN Hawkins","year":"2015","unstructured":"Hawkins PN, Ando Y, Dispenzeri A, Gonzalez-Duarte A, Adams D, Suhr OB (2015) Evolving landscape in the management of transthyretin amyloidosis. Ann Med 47:625\u2013638. https:\/\/doi.org\/10.3109\/07853890.2015.1068949","journal-title":"Ann Med"},{"key":"13218_CR7","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/eurheartj\/ehs123","volume":"34","author":"C Rapezzi","year":"2013","unstructured":"Rapezzi C, Quarta CC, Obici L, Perfetto F, Longhi S, Salvi F, Biagini E, Lorenzini M, Grigioni F, Leone O, Cappelli F, Palladini G, Rimessi P, Ferlini A, Arpesella G, Pinna AD, Merlini G, Perlini S (2013) Disease profile and differential diagnosis of hereditary transthyretin\u2013related amyloidosis with exclusively cardiac phenotype: an Italian perspective. Eur Heart J 34:520\u2013528. https:\/\/doi.org\/10.1093\/eurheartj\/ehs123","journal-title":"Eur Heart J"},{"key":"13218_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10741-014-9462-7","volume":"20","author":"A Castano","year":"2015","unstructured":"Castano A, Drachman BM, Judge D, Maurer MS (2015) Natural history and therapy of TTR\u2013cardiac amyloidosis: emerging dis\u2013 ease\u2013modifying therapies from organ transplantation to stabilizer and silencer drugs. Heart Fail Rev 20:163\u2013178. https:\/\/doi.org\/10.1007\/s10741-014-9462-7","journal-title":"Heart Fail Rev"},{"key":"13218_CR9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1517\/14656566.2016.1145664","volume":"17","author":"D Adams","year":"2016","unstructured":"Adams D, Cauquil C, Labeyrie C, Beaudonnet G, Algalarrondo V, Theaudin M (2016) TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies. Expert Opin Pharmacother 17:791\u2013802. https:\/\/doi.org\/10.1517\/14656566.2016.1145664","journal-title":"Expert Opin Pharmacother"},{"key":"13218_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/WCO.0b013e328357bdf6","volume":"25","author":"D Adams","year":"2012","unstructured":"Adams D, Lozeron P, Lacroix C (2012) Amyloid neuropathies. Curr Opin Neurol 25:564\u2013572. https:\/\/doi.org\/10.1097\/WCO.0b013e328357bdf6","journal-title":"Curr Opin Neurol"},{"key":"13218_CR11","unstructured":"Coutinho P, Martins da Silva A, Lopas LJ (1980) Forty years of experience with type 1 amyloid neuropathy. Review of 483 cases. In: Amyloid and amyloidosis. Excerpta Medica, Amsterdam, pp 88\u201398"},{"key":"13218_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jnnp-2011-301299","volume":"83","author":"H Koike","year":"2012","unstructured":"Koike H, Tanaka F, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Fujitake J, Kawanami T, Kato T, Yamamoto M, Sobue G (2012) Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late\u2013onset cases from non\u2013endemic areas. J Neurol Neurosurg Psychiatry 83:152\u2013158. https:\/\/doi.org\/10.1136\/jnnp-2011-301299","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13218_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3109\/13506129.2012.685665","volume":"19","author":"D Adams","year":"2012","unstructured":"Adams D, Lozeron P, Theaudin M, Mincheva Z, Cauquil C, Adam C, Signate A, Vial C, Maisonobe T, Delmont E, Franques J, Vallat JM, Sole G, Pereon Y, Lacour A, Echaniz-Laguna A, Misrahi M, Lacroix C (2012) Regional difference and similarity of familial amyloidosis with polyneuropathy in France. Amyloid 19:61\u201364. https:\/\/doi.org\/10.3109\/13506129.2012.685665","journal-title":"Amyloid"},{"key":"13218_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1529-8027.2011.00331.x","volume":"16","author":"M Cappellari","year":"2011","unstructured":"Cappellari M, Cavallaro T, Ferrarini M, Cabrini I, Taioli F, Ferrari S, Merlini G, Obici L, Briani C, Fabrizi GM (2011) Variable presentations of TTR\u2013related familial amyloid polyneuropathy in seventeen patients. J Peripher Nerv Syst 16:119\u2013129. https:\/\/doi.org\/10.1111\/j.1529-8027.2011.00331.x","journal-title":"J Peripher Nerv Syst"},{"key":"13218_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1001\/jamaneurol.2024.4631","volume":"82","author":"D Adams","year":"2025","unstructured":"Adams D, Wixner J, Polydefkis M et al (2025) Five-year results with patisiran for hereditary transthyretin amyloidosis with polyneuropathy: a randomized clinical trial with open-label extension. JAMA Neurol 82:228\u2013236. https:\/\/doi.org\/10.1001\/jamaneurol.2024.4631","journal-title":"JAMA Neurol"},{"key":"13218_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/13506129.2020.1855134","volume":"28","author":"MN Ungerer","year":"2021","unstructured":"Ungerer MN, Hund E, Purrucker JC et al (2021) Real\u2013world outcomes in non\u2013endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20\u2013year German single\u2013referral centre experience. Amyloid 28:91\u201399. https:\/\/doi.org\/10.1080\/13506129.2020.1855134","journal-title":"Amyloid"},{"key":"13218_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00415-025-12950-3","volume":"272","author":"V Di Stefano","year":"2025","unstructured":"Di Stefano V, Guaraldi P, Romano A et al (2025) Patisiran in ATTRv amyloidosis with polyneuropathy: \u201cPatisiranItaly\u201d multicenter observational study. J Neurol 272:209. https:\/\/doi.org\/10.1007\/s00415-025-12950-3","journal-title":"J Neurol"},{"key":"13218_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1212\/01.wnl.0000267338.45673.f4","volume":"69","author":"V Plant\u00e9-Bordeneuve","year":"2007","unstructured":"Plant\u00e9-Bordeneuve V, Ferreira A, Lalu T, Zaros C, Lacroix C, Adams D, Said G (2007) Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR\u2013FAP). Neurology 69:693\u2013698. https:\/\/doi.org\/10.1212\/01.wnl.0000267338.45673.f4","journal-title":"Neurology"},{"issue":"2","key":"13218_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1212\/WNL.0000000000005777","volume":"91","author":"P Lozeron","year":"2018","unstructured":"Lozeron P, Mariani LL, Dodet P, Beaudonnet G, Th\u00e9audin M, Adam C, Arnulf B, Adams D (2018) Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy. Neurology 91(2):143\u2013152. https:\/\/doi.org\/10.1212\/WNL.0000000000005777","journal-title":"Neurology"},{"key":"13218_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/jnnp-2016-315262","volume":"88","author":"A Cortese","year":"2017","unstructured":"Cortese A, Vegezzi E, Lozza A, Alfonsi E, Montini A, Moglia A, Merlini G, Obici L (2017) Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy. J Neurol Neurosurg Psychiatry 88:457\u2013458. https:\/\/doi.org\/10.1136\/jnnp-2016-315262","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13218_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/mus.22229","volume":"45","author":"S Mathis","year":"2012","unstructured":"Mathis S, Magy L, Diallo L, Boukhris S, Vallat JM (2012) Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 45:26\u201331. https:\/\/doi.org\/10.1002\/mus.22229","journal-title":"Muscle Nerve"},{"key":"13218_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/mus.25271","volume":"55","author":"A Kaplan","year":"2017","unstructured":"Kaplan A, Brannagan TH 3rd (2017) Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 55:476\u2013482. https:\/\/doi.org\/10.1002\/mus.25271","journal-title":"Muscle Nerve"},{"key":"13218_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/13506129.2019.1672649","volume":"27","author":"C Karam","year":"2020","unstructured":"Karam C, Dimitrova D, Heitner SB (2020) Misdiagnosis of hATTR amyloidosis: a single US site experience. Amyloid 27:69\u201370. https:\/\/doi.org\/10.1080\/13506129.2019.1672649","journal-title":"Amyloid"},{"key":"13218_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jns.12362","volume":"25","author":"M Campagnolo","year":"2020","unstructured":"Campagnolo M, Taioli F, Cacciavillani M, Ruiz M, Luigetti M, Salvalaggio A, Castellani F, Testi S, Ferrarini M, Cavallaro T, Gasparotti R, Fabrizi GM, Briani C (2020) Sporadic hereditary neuropathies misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: Pitfalls and red flags. J Peripher Nerv Syst 25:19\u201326. https:\/\/doi.org\/10.1111\/jns.12362","journal-title":"J Peripher Nerv Syst"},{"key":"13218_CR25","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1111\/ene.14959","volume":"28","author":"PYK van den Bergh","year":"2021","unstructured":"van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, Attarian S, Blomkwist Markens PH, Cornblath DR, Eftimov F, Goedee HS, Harbo T, Kuwabara S, Lewis RA, Lunn MP, Nobile Orazio E, Querol L, Rajabally YA, Sommer C, Topaloglu HA (2021) European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision. Eur J Neurol 28:3556\u20133583. https:\/\/doi.org\/10.1111\/ene.14959","journal-title":"Eur J Neurol"},{"key":"13218_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3109\/13506129.2011.565524","volume":"18","author":"H Koike","year":"2011","unstructured":"Koike H, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Tanaka F, Sobue G (2011) Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Amyloid 18:53\u201362. https:\/\/doi.org\/10.3109\/13506129.2011.565524","journal-title":"Amyloid"},{"key":"13218_CR27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S1474-4422(18)30071-1","volume":"17","author":"N Attal","year":"2018","unstructured":"Attal N, Bouhassira D, Baron R (2018) Diagnosis and assessment of neuropathic pain through questionnaires. Lancet Neurol 17:456\u2013466. https:\/\/doi.org\/10.1016\/S1474-4422(18)30071-1","journal-title":"Lancet Neurol"},{"key":"13218_CR28","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","volume":"87","author":"DM Sletten","year":"2012","unstructured":"Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W (2012) COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc 87:1196\u20131201. https:\/\/doi.org\/10.1016\/j.mayocp.2012.10.013","journal-title":"Mayo Clin Proc"},{"key":"13218_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"PY van den Bergh","year":"2010","unstructured":"van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, Koski CL, L\u00e9ger JM, Nobile Orazio E, Pollard J, Sommer C, van Doorn PA, van Schaik IN, European Federation of Neurological Societies; Peripheral Nerve Society (2010) European federation of neurological societies\/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European federation of neurological societies and the peripheral nerve society\u2014first revision. Eur J Neurol 17:356\u2013363. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02930.x","journal-title":"Eur J Neurol"},{"key":"13218_CR30","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s00415-018-09174-z","volume":"266","author":"A Breiner","year":"2019","unstructured":"Breiner A, Moher D, Brooks J, Cheng W, Hegen H, Deisenhammer F, McCudden CR, Bourque PR (2019) Adult CSF total protein upper reference limits should be age\u2013partitioned and significantly higher than 0.45 g\/L: a systematic review. J Neurol 266:616\u2013624. https:\/\/doi.org\/10.1007\/s00415-018-09174-z","journal-title":"J Neurol"},{"issue":"85","key":"13218_CR31","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1212\/wnl.0000000000001833","volume":"11","author":"JA Allen","year":"2015","unstructured":"Allen JA, Lewis RA (2015) CIDP diagnostic pitfalls and perception of treatment benefit. Neurology 11(85):498\u2013504. https:\/\/doi.org\/10.1212\/wnl.0000000000001833","journal-title":"Neurology"},{"key":"13218_CR32","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1111\/ene.14796","volume":"28","author":"MC Broers","year":"2021","unstructured":"Broers MC, Bunschoten C, Drenthen J, Beck TAO, Brusse E, Lingsma HF, Allen JA, Lewis RA, van Doorn PA, Jacobs BC (2021) Misdiagnosis and diagnostic pitfalls of chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 28:2065\u20132073. https:\/\/doi.org\/10.1111\/ene.14796","journal-title":"Eur J Neurol"},{"key":"13218_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13023-025-03589-4","volume":"20","author":"Y P\u00e9r\u00e9on","year":"2025","unstructured":"P\u00e9r\u00e9on Y, Adams D, Camdessanch\u00e9 JP, Chanson JB, Cintas P, Magy L, Signat\u00e9 A, Sol\u00e9 G, Svahn J, Tard C, Hababou C, Attarian S (2025) Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective study. Orphanet J Rare Dis 20:95. https:\/\/doi.org\/10.1186\/s13023-025-03589-4","journal-title":"Orphanet J Rare Dis"},{"key":"13218_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/13506129.2018.1564903","volume":"26","author":"N Ohashi","year":"2019","unstructured":"Ohashi N, Kodaira M, Morita H, Sekijima Y (2019) Electrophysiological demyelinating features in hereditary ATTR amyloidosis. Amyloid 26:15\u201323. https:\/\/doi.org\/10.1080\/13506129.2018.1564903","journal-title":"Amyloid"},{"key":"13218_CR35","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1007\/s10072-020-04717-7","volume":"41","author":"L Leonardi","year":"2020","unstructured":"Leonardi L, Vanoli F, Fionda L, Loreti S, Garibaldi M, Morino S, Salvetti M, Russo D, Musumeci B, Antonini G (2020) Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy. Neurol Sci 41:3775\u20133778. https:\/\/doi.org\/10.1007\/s10072-020-04717-7","journal-title":"Neurol Sci"},{"key":"13218_CR36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12875-020-01252-4","volume":"21","author":"M Gertz","year":"2020","unstructured":"Gertz M, Adams D, Ando Y, Beir\u00e3o JM, Bokhari S, Coelho T, Comenzo RL, Damy T, Dorbala S, Drachman BM, Fontana M, Gillmore JD, Grogan M, Hawkins PN, Lousada I, Kristen AV, Ruberg FL, Suhr OB, Maurer MS, Nativi-Nicolau J, Quarta CC, Rapezzi C, Witteles R, Merlini G (2020) Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. BMC Fam Pract 21:198. https:\/\/doi.org\/10.1186\/s12875-020-01252-4","journal-title":"BMC Fam Pract"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13218-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13218-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13218-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T02:41:36Z","timestamp":1756608096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13218-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["13218"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13218-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pietro Emiliano Doneddu reports personal fees for Advisory from ArgenX, and received travel grants to attend scientific meetings from CSL Behring, and Kedrion. Giuseppe Cosentino has received travel grants to attend scientific meetings from CSL Behring, and Kedrion. Massimiliano Filosto has served on scientific advisory boards for CSL Behring, Sanofi, and Amicus, and has received travel grants from Sanofi, Biogen, Kedrion, and CSL Behring to attend scientific meeting. Anna Mazzeo has received travel grants from Kedrion, and CSL Behring to attend scientific meeting. Maurizio Inghilleri has received travel grants to attend scientific meetings from CSL Behring, ArgenX, and Alexion. Federica Moret has received travel grants to attend scientific meetings from CSL Behring, ArgenX, and Alexion. Eduardo Nobile-Orazio reports personal fees for Advisory or Scientific Board from ArgenX \u2013 Belgium, Takeda \u2013 Italy and USA, CSL-Behring\u2014Italy and USA, Janssen \u2013 USA, Kedrion \u2013 Italy, LFB \u2013 France, Roche\u2013 Switzerland, Sanofi\u2014USA. The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of each participating center and was conducted in accordance with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"515"}}